{"id":"W2057093576","doi":"10.1016/j.pain.2013.05.051","title":"Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in the treatment of patients with moderate to severe osteoarthritis pain","year":2013,"lang":"en","type":"article","venue":"Pain","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; Placebo; Osteoarthritis; Analgesic; Brief Pain Inventory; Adverse effect; Anesthesia; Chronic pain; Internal medicine; Randomized controlled trial; Physical therapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006942584,0.0002320258,0.0005716564,0.00009274236,0.00005047403,0.00001784095,0.00007484273,0.00007460134,0.00007524557],"category_scores_gemma":[0.0001095316,0.0001418279,0.00006589794,0.0001777511,0.00007498018,0.0001209868,0.00001567435,0.0000600997,0.000003749802],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004976898,"about_ca_system_score_gemma":0.00003607606,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004676225,"about_ca_topic_score_gemma":0.0003124459,"domain_scores_codex":[0.9979749,0.0007778573,0.0003867655,0.0003210029,0.0002770741,0.0002624113],"domain_scores_gemma":[0.9988758,0.0003727623,0.00009884352,0.0003652899,0.0001461781,0.0001411088],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001660491,0.003151671,0.6745563,0.0001125715,0.00003786688,0.00002166328,0.005141307,0.000009793559,0.002799473,0.00006223778,0.000008065007,0.3124386],"study_design_scores_gemma":[0.01983607,0.03995431,0.9320297,0.0003567435,0.00007497321,0.000007453915,0.0007436646,0.0002683586,0.006153238,0.0001840913,0.000108713,0.0002826778],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965482,0.0001477157,0.0002257487,0.0002712175,0.00002243494,0.002535175,0.0001293864,0.00001874179,0.0001013978],"genre_scores_gemma":[0.9988284,0.000048231,0.0006523739,0.0001276191,0.00001983744,0.00007271971,0.0002035166,0.00002056558,0.00002672705],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3121559,"threshold_uncertainty_score":0.5783576,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009762249642721649,"score_gpt":0.2375900371841291,"score_spread":0.2278277875414075,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}